Purine analogs in lymphoproliferative disorders.
Cheson
B D
BD
Medicine Section, National Cancer Institute, Bethesda, MD 20892.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000188:drug therapy; D015649:Pentostatin / Q000009:adverse effects / Q000627:therapeutic use*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D015649:Pentostatin; D017338:Cladribine; D014740:Vidarabine; C024352:fludarabine